Treatment of post‐treatment Lyme disease symptoms—a systematic review
European Journal of Neurology · 2024-07 · 31 (7)
DOI: 10.1111/ene.16293 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Neurology, online erschienen am 12.04.2024. Verfasst von Rick Dersch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Lyme Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Neurological Society.
Abstract (Originalsprache)
Background and purpose Residual symptoms after treatment of Lyme disease, sometimes called post‐treatment Lyme disease symptoms (PTLDs), are a matter of ongoing controversy. To guide treatment recommendations, a systematic review was performed of the available literature on specific treatment for PTLDs.
Methods
A systematic literature search of MEDLINE and CENTRAL was performed. No restrictions on case definitions, study types or specific interventions were applied to enable a comprehensive overview of the available literature. Risk of bias was assessed using the Cochrane risk of bias tools for randomized controlled trials. Certainty of the evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation approach. Outcomes of interest were quality of life, fatigue, depression and cognition as well as adverse events.
Results
After screening 1274 records, eight eligible randomized controlled trials were included. Heterogeneity was observed regarding inclusion criteria, intervention, length of treatment and outcome measures. For efficacy outcomes, results are presented narratively due to heterogeneity. Eligible studies show no statistically significant difference between antibiotics and placebo regarding quality of life, cognition and depression. Results for fatigue were inconsistent whilst studies with low risk of bias showed no statistically significant difference between antibiotics and placebo. Meta‐analysis of safety outcomes showed statistically significantly more adverse events for antibiotics compared to placebo.
Conclusions
Available literature on treatment of PTLDs is heterogeneous, but overall shows evidence of no effect of antibiotics regarding quality of life, depression, cognition and fatigue whilst showing more adverse events. Patients with suspected PTLDs should not be treated with antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Pediatrics, Paracelsus Medical University, Klinikum Nürnberg, Universitätsklinik der Paracelsus Medizinischen Privatuniversität Nürnberg, Nuremberg, Germany.
ORCID-Profile: Rick Dersch, Gabriel Torbahn
Förderung
- German Neurological Society
Zitieren
APA
Dersch, R., Torbahn, G., & Rauer, S. (2024). Treatment of post‐treatment Lyme disease symptoms—a systematic review. European Journal of Neurology, 31(7). https://doi.org/10.1111/ene.16293
Vancouver
Dersch R, Torbahn G, Rauer S. Treatment of post‐treatment Lyme disease symptoms—a systematic review. European Journal of Neurology. 2024;31(7). doi:10.1111/ene.16293
BibTeX
@article{Dersch2024,
author = {Dersch, Rick and Torbahn, Gabriel and Rauer, Sebastian},
title = {Treatment of post‐treatment Lyme disease symptoms—a systematic review},
journal = {European Journal of Neurology},
year = {2024},
volume = {31},
number = {7},
doi = {10.1111/ene.16293}
}
EUVIMED